NSE ScannerComparison · NSE · data 2026-11-01
Bharat Parenterals Ltd. vs Venus Remedies Limited
In plain words
Size: Venus Remedies Limited is about 1.2 times the market value of Bharat Parenterals Ltd..
Valuation (P/E): Bharat Parenterals Ltd. 1,124.7 vs Venus Remedies Limited 13.6.
Return on equity: Venus Remedies Limited 16.8% vs Bharat Parenterals Ltd. -2.5%.
Debt to equity: Bharat Parenterals Ltd. 0.45 vs Venus Remedies Limited 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BPLPHARMA | VENUSREM | |
|---|---|---|
| Price | ₹2,029.9 | ₹1,238.6 |
| Market cap | ₹1,397 cr | ₹1,646 cr |
| P/E | 1,124.7 | 13.6 |
| P/B | 4.2 | 2.4 |
| ROE | -2.5% | 16.8% |
| ROCE | -4.2% | 14.5% |
| Debt / equity | 0.45 | 0.02 |
| Operating margin | -0.4% | 17.7% |
| Dividend yield | 0.05% | 0.81% |
| Sales growth, 3 years (yearly) | 16.5% | 10.1% |
| Profit growth, 3 years (yearly) | — | 57.0% |
| 1-year return | 45.0% | 182.9% |
| Revenue, last 12 months | ₹395 cr | ₹837 cr |
| Net profit, last 12 months | ₹1 cr | ₹122 cr |
| Latest quarter | — | Sept 2026 |
| Quarter net profit | — | ₹26 cr |
| Quarter profit vs a year earlier | — | +27.4% |
| Promoter holding | — | 41.76% |
| Health check | Average (5/10) | Strong (8/10) |
Common questions
Which has a higher P/E, Bharat Parenterals Ltd. or Venus Remedies Limited?
Bharat Parenterals Ltd. trades at the higher P/E (1,124.7 against 13.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Venus Remedies Limited (16.8% against -2.5%).
Which carries more debt?
Bharat Parenterals Ltd. has the higher debt-to-equity ratio (0.45 against 0.02).